Severe Eosinophilic Asthma: Key Decisions That Drive Effective Strategies with Targeted Therapies

Gain expert guidance on current best practice for the treatment of severe asthma including an Interactive Decision Support Tool and expert commentaries.

Share

Program Content

No activities added yet

No activities added yet

Provided by

ProCE Banner

Supporters

This activity is supported by educational grants from

Novartis Pharmaceuticals Corporation

Sanofi Genzyme and Regeneron Pharmaceuticals